Dalian Jingang-Andi Bio-Products Co. Ltd., whose products are sold under the brand name “JGAD,” completed a reverse merger with China Bio-Immunity Corporation. JGAD is a vaccine maker that derives the majority of its revenue from a rabies vaccine. In exchange for 13,246,697 shares of China Bio-Immunity’s stock, all of JGAD was transferred into China Bio-Immunity. The $9.50 share price of China Bio-Immunity gives the newly reconstituted company a market capitalization of $158 million. More details...

Stock Symbol: (OTCBB: CHHB)